ArticleOncology letters2022

Capecitabine inhibits epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells by mediating the RANK/RANKL pathway.

Minghai Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.